Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 9/20 | 0.71 |
| ▸ | CYSLTR2 | Q9NS75 | 6/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.66 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.66 |
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9053968 | 0.91 | ALOX5 (0.64) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL8646512 | 0.84 | CYSLTR1 (1.00) | CYSLTR1CYSLTR2FFAR1AKR1B1 | |
| SCHEMBL7813788 | 0.83 | CYSLTR1 (0.70) | CYSLTR1CYSLTR2FFAR1AKR1B1PDE10A | |
| SCHEMBL10692490 | 0.81 | ALOX5 (1.00) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL8649544 | 0.80 | FFAR1 (0.97) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL1419872 | 0.78 | FFAR1 (0.77) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL8712492 | 0.78 | CYSLTR1 (0.75) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL10545819 | 0.77 | CYSLTR1 (1.00) | CYSLTR1CYSLTR2FFAR1AKR1B1 | |
| SCHEMBL9054252 | 0.77 | CYSLTR1 (0.61) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL8712313 | 0.77 | CYSLTR1 (0.73) | CYSLTR1CYSLTR2FFAR1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996004246-A1 | PHENYLACETAMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION | LABORATORIOS MENARINI S.A. (ES) | 1996-02-15 | — | — | WO | claimed |